Announced
Completed
Synopsis
European healthcare investment firm ArchiMed completed the acquisition of a majority stake in Namsa, a medical device testing company. Financial terms were not disclosed. Namsa chose ArchiMed in part because of its knowledge of the European market, one of the areas where Namsa hopes to expand. The deal is expected to close in September.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.